Does The U.S. Need The Private Space Station?

Volume 2, #12 The Scientist June 27, 1988 Does The U.S. Need The Private Space Station?   U.S. competitiveness will suffer if we don't build it now, by Gregg R. Fawkes Let's find out who will use it before we waste a billion dollars, by John Pike Date: June 27, 1988 Two years ago, the explosion of the space shuttle Challenger etched its searing images on minds of the U.S. public—and crippled the country’s space effort Experiments, satellites, and

Written byJohn Carey
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Two years ago, the explosion of the space shuttle Challenger etched its searing images on minds of the U.S. public—and crippled the country’s space effort Experiments, satellites, and probes, already backlogged by delays in the shuttle program, were grounded. Many scientists and companies began to look for alternative launch systems and space platforms to carry their projects.

So too did the Reagan administration. Officials began to worry that U.S. industry, unable to perform experiments in the near-weightlessness of space, would fall behind foreign competitors in the race to develop new materials and materials-processing techniques. Even the return to service of the space shuttle wouldn’t solve the problem; its microgravity was too strong, its time in space too short What was really needed, administration experts said, was an orbiting space platform. But the National Aeronautics and Space Administration’s grandiose, expensive, and controversial manned space station would not be ready until 1998, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies